Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This batch came in at 99.6% the highest weve recorded
Do not share this article without checking with the recipient in advance.** In March of this year (2025), the NHS approved the GLP-1 receptor agonist Mounjaro for the treatment of obesity
The findings of this meta-analysis suggest that GLP-1 receptor agonists are not associated with an increased risk of gastrointestinal cancers and were not associated with increased gastrointestinal cancer risk and demonstrated pooled estimates below unity for colorectal and liver cancers, findings that should be interpreted as hypothesis-generating rather than confirmatory of cancer prevention (Lingvay et al., 2018
Want to improve your long-term health
Hard lumps beneath the skin that persist for more than two weeks may indicate lipodystrophy or another injection site reaction that needs evaluation
Pestic Biochem Physiol 104:5864
